v3.26.1
UNAUDITED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Millions
Total
Restricted shares
Restricted stock units
Total stockholders’ equity attributable to T. Rowe Price Group
Total stockholders’ equity attributable to T. Rowe Price Group
Restricted shares
Total stockholders’ equity attributable to T. Rowe Price Group
Restricted stock units
Common stock
Common stock
Restricted shares
Common stock
Restricted stock units
Additional capital in excess of par value
Additional capital in excess of par value
Restricted shares
Additional capital in excess of par value
Restricted stock units
Retained earnings
AOCI
[1]
Non-controlling interests in consolidated entities
Beginning balances (in shares) at Dec. 31, 2024             222,966                
Beginning balances at Dec. 31, 2024 $ 10,506.1     $ 10,345.4     $ 44.6     $ 311.9     $ 10,040.6 $ (51.7) $ 160.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net income (loss) 993.8     995.7                 995.7   (1.9)
Other comprehensive (loss) income, net of tax 7.1     7.1                   7.1  
Dividends declared (574.9)     (574.9)                 (574.9)    
Common stock-based compensation plans activity:                              
Shares issued upon option exercises (in shares)             264                
Shares issued upon option exercises 17.2     17.2     $ 0.1     17.1          
Net shares issued upon vesting of restricted stock units (in shares)                 15            
Net shares issued upon vesting of restricted stock units     $ (0.6)     $ (0.6)           $ (0.6)      
Stock-based compensation expense 96.9     96.9           96.9          
Restricted stock units issued as dividend equivalents                   0.1     (0.1)    
Common shares repurchased (in shares)             (3,351)                
Common shares repurchased (326.1)     (326.1)     $ (0.7)     (325.4)          
Net distributions to non-controlling interests in consolidated entities (5.5)                           (5.5)
Ending balances (in shares) at Jun. 30, 2025             219,902                
Ending balances at Jun. 30, 2025 10,713.8     10,560.5     $ 44.0     99.8     10,461.3 (44.6) 153.3
Beginning balances attributable to redeemable non-controlling interests at Dec. 31, 2024 944.0                            
Increase (Decrease) in Temporary Equity [Roll Forward]                              
Net income (loss) 65.5                            
Other comprehensive (loss) income, net of tax 11.0                            
Net subscriptions into T. Rowe Price investment products 259.7                            
Net deconsolidations of T. Rowe Price investment products (181.1)                            
Ending balances attributable to redeemable non-controlling interests at Jun. 30, 2025 1,099.1                            
Beginning balances (in shares) at Mar. 31, 2025             221,061                
Beginning balances at Mar. 31, 2025 10,555.1     10,394.7     $ 44.2     160.2     10,242.2 (51.9) 160.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net income (loss) 503.7     505.2                 505.2   (1.5)
Other comprehensive (loss) income, net of tax 7.3     7.3                   7.3  
Dividends declared (286.1)     (286.1)                 (286.1)    
Common stock-based compensation plans activity:                              
Shares issued upon option exercises (in shares)             33                
Shares issued upon option exercises 2.0     2.0     $ 0.1     1.9          
Restricted shares issued, net of shares withheld for taxes (in shares)               8              
Restricted shares issued, net of shares withheld for taxes   $ (0.2)     $ (0.2)           $ (0.2)        
Net shares issued upon vesting of restricted stock units (in shares)                 10            
Net shares issued upon vesting of restricted stock units     (0.4)     (0.4)           (0.4)      
Stock-based compensation expense 46.6     46.6           46.6          
Common shares repurchased (in shares)             (1,210)                
Common shares repurchased (108.6)     (108.6)     $ (0.3)     (108.3)          
Net distributions to non-controlling interests in consolidated entities (5.6)                           (5.6)
Ending balances (in shares) at Jun. 30, 2025             219,902                
Ending balances at Jun. 30, 2025 10,713.8     10,560.5     $ 44.0     99.8     10,461.3 (44.6) 153.3
Beginning balances attributable to redeemable non-controlling interests at Mar. 31, 2025 977.2                            
Increase (Decrease) in Temporary Equity [Roll Forward]                              
Net income (loss) 50.9                            
Other comprehensive (loss) income, net of tax 7.9                            
Net subscriptions into T. Rowe Price investment products 169.1                            
Net deconsolidations of T. Rowe Price investment products (106.0)                            
Ending balances attributable to redeemable non-controlling interests at Jun. 30, 2025 1,099.1                            
Beginning balances (in shares) at Dec. 31, 2025             218,565                
Beginning balances at Dec. 31, 2025 11,017.2     10,860.1     $ 43.8     0.0     10,866.8 (50.5) 157.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net income (loss) 1,148.4     1,130.2                 1,130.2   18.2
Other comprehensive (loss) income, net of tax (7.7)     (7.7)                   (7.7)  
Dividends declared (572.3)     (572.3)                 (572.3)    
Common stock-based compensation plans activity:                              
Shares issued upon option exercises (in shares)             13                
Shares issued upon option exercises 0.9     0.9           0.9          
Restricted shares issued, net of shares withheld for taxes (in shares)               5              
Restricted shares issued, net of shares withheld for taxes   (0.3)     (0.3)           (0.3)        
Net shares issued upon vesting of restricted stock units (in shares)                 14            
Net shares issued upon vesting of restricted stock units     (0.7)     (0.7)           (0.7)      
Forfeiture of restricted awards (in shares)                 (18)            
Stock-based compensation expense 89.8     89.8           89.8          
Restricted stock units issued as dividend equivalents                   0.3     (0.3)    
Common shares repurchased (in shares)             (5,267)                
Common shares repurchased (497.5)     (497.5)     $ (1.1)     (90.0)     (406.4)    
Net distributions to non-controlling interests in consolidated entities (14.3)                           (14.3)
Ending balances (in shares) at Jun. 30, 2026             213,312                
Ending balances at Jun. 30, 2026 11,163.5     11,002.5     $ 42.7     0.0     11,018.0 (58.2) 161.0
Beginning balances attributable to redeemable non-controlling interests at Dec. 31, 2025 1,036.0                            
Increase (Decrease) in Temporary Equity [Roll Forward]                              
Net income (loss) 49.3                            
Other comprehensive (loss) income, net of tax (1.6)                            
Net subscriptions into T. Rowe Price investment products 128.5                            
Net deconsolidations of T. Rowe Price investment products (202.9)                            
Ending balances attributable to redeemable non-controlling interests at Jun. 30, 2026 1,009.3                            
Beginning balances (in shares) at Mar. 31, 2026             214,880                
Beginning balances at Mar. 31, 2026 10,935.2     10,777.6     $ 43.1     0.0     10,786.1 (51.6) 157.6
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net income (loss) 638.8     632.0                 632.0   6.8
Other comprehensive (loss) income, net of tax (6.6)     (6.6)                   (6.6)  
Dividends declared (283.9)     (283.9)                 (283.9)    
Common stock-based compensation plans activity:                              
Shares issued upon option exercises (in shares)             9                
Shares issued upon option exercises 0.6     0.6           0.6          
Restricted shares issued, net of shares withheld for taxes (in shares)               5              
Restricted shares issued, net of shares withheld for taxes   $ (0.3)     $ (0.3)           $ (0.3)        
Net shares issued upon vesting of restricted stock units (in shares)                 9            
Net shares issued upon vesting of restricted stock units     $ (0.5)     $ (0.5)           $ (0.5)      
Forfeiture of restricted awards (in shares)                 (18)            
Stock-based compensation expense 40.7     40.7           40.7          
Restricted stock units issued as dividend equivalents                   0.1     (0.1)    
Common shares repurchased (in shares)             (1,573)                
Common shares repurchased (157.1)     (157.1)     $ (0.4)     (40.6)     (116.1)    
Net distributions to non-controlling interests in consolidated entities (3.4)                           (3.4)
Ending balances (in shares) at Jun. 30, 2026             213,312                
Ending balances at Jun. 30, 2026 11,163.5     $ 11,002.5     $ 42.7     $ 0.0     $ 11,018.0 $ (58.2) $ 161.0
Beginning balances attributable to redeemable non-controlling interests at Mar. 31, 2026 940.2                            
Increase (Decrease) in Temporary Equity [Roll Forward]                              
Net income (loss) 63.4                            
Other comprehensive (loss) income, net of tax (0.9)                            
Net subscriptions into T. Rowe Price investment products 11.4                            
Net deconsolidations of T. Rowe Price investment products (4.8)                            
Ending balances attributable to redeemable non-controlling interests at Jun. 30, 2026 $ 1,009.3                            
[1] Accumulated other comprehensive income